Company Information
CIN
Status
Date of Incorporation
31 October 1995
State / ROC
Hyderabad / ROC Hyderabad
Last Balance Sheet
31 March 2022
Last Annual Meeting
30 September 2022
Paid Up Capital
549,999,980
Authorised Capital
550,000,000
Directors
Rama Krishna Reddy Isanaka
Director/Designated Partner
almost 3 years ago
almost 3 years ago
Lakshminarayana Reddy Isanaka
Director/Designated Partner
about 9 years ago
about 9 years ago
Vijay Krishna Akepati .
Director
almost 20 years ago
almost 20 years ago
Past Directors
Tatavarthy Satyanarayana Murthy
Additional Director
about 9 years ago
about 9 years ago
Isanaka Shaalini
Additional Director
over 9 years ago
over 9 years ago
Srinivasa Rao Ramaraju
Director
over 14 years ago
over 14 years ago
Sheila Isanaka
Director
almost 20 years ago
almost 20 years ago
Seenayya Gunda
Director
over 21 years ago
over 21 years ago
Rajeswari Isanaka
Director
over 21 years ago
over 21 years ago
Patents
A method to treat angiogenesis and inflammatory related diseases, by treating a patient with at least one peptide sequence possessing physico-chemical relatedness with SEQ ID NO: 54 (JC15-10N).
1. A peptide of the sequence: FAKKFAKKFKKFAKKFAKFAFAF and any derivative, analog thereof in a therapeutic dose found in any useful preparation thereof.
- Not Applicable-
ABSTRACT
‘A COMPOSITION FOR THE TREATMENT OF CHRONIC WOUNDS AND BURNS’
The present invention provides an effective composition for treating burns, diabetic wounds and other type of chronic wounds including treatment of eroded or cracked tissue. The composition shows enhanced therapeutic effect in wound healing and...
Registered Trademarks
[Class : 5] Peptide Based Pharmaceutical Preparations For The Treatment Of Diseases Including Inter Alia Tumors, Melanomas, Viral Infection, Arthritis, Age Dependent Muscular Degeneration, Psoriasis, Psoriasis Arthritis, Restenosis, Obesity, Pulmonary Hypertension, Chronic Respiratory Diseases, Dementia, Vascular Malformations, Inflammatory Bowel Disease, Ulcerative Colitis,...
[Class : 5] Synthetic Peptides For Pharmaceutical Purposes; Amino Acids For Medical Purposes; Dietetic Substances Consisting Of Vitamins, Minerals, Amino Acids And Trace Elements; Pharmaceutical, Medical And Veterinary Preparations.
[Class : 41] Conducting Of Workshops And Seminars In Art Appreciation; Presentation Of Works Of Visual Art And Literature To The Public For Cultural Or Educational Purposes.
View +34 more Brands for Issar Pharmaceuticals Private Limited.
Charges
16 June 2011
State Bank Of India
24 Crore
05 June 2006
Uti Bank Limited
1 Crore
19 November 2003
Karnataka Bank
5 Lak
12 November 2005
The Karnataka Bank Limited
25 Lak
05 April 2003
Technology Development Board
2 Crore
12 November 2005
The Karnataka Bank Limited
0
19 November 2003
Karnataka Bank
0
16 June 2011
State Bank Of India
0
12 November 2005
The Karnataka Bank Limited
0
05 April 2003
Technology Development Board
0
05 June 2006
Uti Bank Limited
0
12 November 2005
The Karnataka Bank Limited
0
19 November 2003
Karnataka Bank
0
16 June 2011
State Bank Of India
0
12 November 2005
The Karnataka Bank Limited
0
05 April 2003
Technology Development Board
0
05 June 2006
Uti Bank Limited
0
12 November 2005
The Karnataka Bank Limited
0
19 November 2003
Karnataka Bank
0
16 June 2011
State Bank Of India
0
12 November 2005
The Karnataka Bank Limited
0
05 April 2003
Technology Development Board
0
05 June 2006
Uti Bank Limited
0
12 November 2005
The Karnataka Bank Limited
0
Documents
Form DPT-3-03062020-signed
Form MGT-7-02012020_signed
List of share holders, debenture holders;-31122019
Copy of MGT-8-31122019
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-29122019
Form AOC-4(XBRL)-29122019_signed
Form DPT-3-02072019
Form MGT-14-26042019-signed
Form PAS-3-05042019_signed
List of allottees. Attach separate list for each allotment (refer instruction kit for format).If not attached, then it shall be submitted separately in a CD.-29032019
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-29032019
Optional Attachment-(2)-29032019
Optional Attachment-(1)-29032019
Copy of Board or Shareholders? resolution-29032019
Form MGT-7-02012019_signed
Copy of MGT-8-27122018
List of share holders, debenture holders;-27122018
Form AOC-4(XBRL)-27122018_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-25122018
Form SH-7-12092018-signed
Form MGT-14-11092018-signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-30082018
Copy of the resolution for alteration of capital;-30082018
Altered articles of association-30082018
Altered memorandum of assciation;-30082018
Altered articles of association;-30082018
Altered memorandum of association-30082018
Form AOC-4(XBRL)-12022018_signed
Form MGT-7-12022018_signed
List of share holders, debenture holders;-06022018
